IU, Purdue get $2.55M to study breast cancer

  • Comments
  • Print

Researchers at Indiana University and Purdue University have received $2.55 million from Susan G. Komen to study possible new treatments.

IU and its researchers will get $2.1 million to study why some patients suffer chemotherapy-related side effects; to understand how RNA controls genes in breast cancer; to understand the molecular mechanisms involved in estrogen-receptor positive cancer growth; and to support the collection and storage of whole blood, DNA serum, plasma and healthy breast tissue at the IU Simon Cancer Center.

Purdue and its researchers will get $450,000 to study how to enhance the immune system’s natural ability to fight breast cancer through the protein PD-L1.•

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.